Dr Hari Nair (Managing Director)
Dr Nair has a PhD in Medicine and Clinical Science from the Australian National University.  Dr Nair has run biotechnology companies in Australia and the United States.  Dr Nair is the former CEO and Managing Director of Life Therapeutics.  Life Therapeutics is the world leader in the collection of hyperimmune plasmas.  Life Therapeutics has, under Dr Nair’s leadership transformed into a vibrant commercial relevant organisation with plasma collection centers around the United States.  In the last decade, he has been involved in the strategy and implementation of global expansion policies in biotechnology.  Dr Nair has been heavily involved in Mergers and Acquisitions especially in the United States and Europe.  He lives and works in the United States and has US financial strategy experience. 

John Manusu (Executive Chairman)
Mr Manusu has over 20 years experience running biotechnology companies.  He has been involved with startups, turnarounds and mature organizations in the biotechnology space.  He was until recently an Executive Director of Life Therapeutics and was, with Dr Nair, responsible for the turnaround of this company.  Mr Manusu has undertaken a number of significant acquisitions and divestures, as well as raising over $100 million in public funding and $10 million of peer reviewed government R&D grants.  Mr Manusu has a degree in Commerce and is an Associate of the Australian Securities Institute.  Mr Manusu has worked in the biotechnology industry in Australia and the U.S. and is best described as a biotechnology entrepreneur.  Mr Manusu is a non-executive Director of Life Therapeutics. 

Dr John Andrews (Chief Scientific Officer)
Dr Andrews has in excess of 20 years skilled practice in chemistry/biochemistry R&D, particularly separations science and protein chemistry, across the biomedical, agricultural and biotechnology industries.  He has a BA (Honours-I-Chemistry) from Macquarie University and a PhD from the University of Sydney. Working under a range of regulatory environments (GMP/GLP/ISO), he has significant experience  in areas of production, product/process development and analytical/process validation.  He has managed research, process development and production teams, of varying sizes, at institutions such as Bond University, CSIRO, Biotech Australia and Gropep. His relationship with Life Therapeutics dates back to the late 90’s when he served on the Scientific Advisory Committee of the Gels division.

Prakash Patel (COO and Company Secretary)
Mr Patel has a degree in Commerce and is a CPA, he has several years of post qualification experience holding senior Finance roles in listed multinational companies working both in Sydney and the United Kingdom.  Mr Patel has overall responsibility for all aspects of the group and has a lead role in commercial decision-making across the business. Mr Patel is responsible for all dealings with the Australian Stock Exchange, Investors and Shareholders.